NovoCure Limited - Ordinary Shares (NQ:NVCR)

15.73 +0.18 (+1.19%)

Streaming Delayed Price Updated: 1:08 PM EDT, Jul 15, 2026 Add to My Watchlist

Price and Volume

Volume	245,816
Open	15.52
Bid (Size)	15.71 (200)
Ask (Size)	15.76 (100)
Prev. Close	15.55
Today's Range	15.31 - 15.91
52wk Range	9.820 - 18.92
Shares Outstanding	103,647,871
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NovoCure Limited - NVCR

July 14, 2026

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NovoCure Limited - NVCR

July 07, 2026

From Pomerantz LLP

Via GlobeNewswire

Performance

YTD	+19.9%	+19.9%
1 Month	-10.6%	-10.6%
3 Month	+39.2%	+39.2%
6 Month	+15.3%	+15.3%
1 Year	-9.7%	-9.7%

More News

Novocure to Report Second Quarter 2026 Financial Results

July 01, 2026

From Novocure

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NovoCure Limited - NVCR

June 30, 2026

From Pomerantz LLP

Via GlobeNewswire

Novocure (NASDAQ: NVCR) Q1 Revenue Beat and Path to Profitability Drive 9% Share Jump ↗

April 30, 2026

Via Chartmill

Novocure Ltd (NASDAQ:NVCR) Reports Mixed Q4 2025 Results, Stock Falls on Revenue Miss ↗

February 26, 2026

Via Chartmill

Novocure’s Optune Pax® Receives CE Mark for the Treatment of Locally Advanced Pancreatic Cancer

June 30, 2026

From Novocure

Via Business Wire

HeartFlow vs. NovoCure: Which Emerging Healthcare Stock Is a Better Buy in 2026? ↗

June 24, 2026

Via The Motley Fool

NovoCure vs. Omeros: Which Emerging Pharmaceutical Stock Is a Better Buy in 2026? ↗

June 22, 2026

Via The Motley Fool

NVCR Investors Have Opportunity to Join NovoCure Limited Fraud Investigation with the Schall Law Firm

June 20, 2026

From The Schall Law Firm

Via Business Wire

Amgen vs. NovoCure: Which Health Care Stock Is a Better Buy in 2026? ↗

June 19, 2026

Via The Motley Fool

Thursday's session: gap up and gap down stocks ↗

June 18, 2026

Via Chartmill

These stocks that are showing activity before the opening bell on Thursday. ↗

June 18, 2026

Via Chartmill

Novocure Announces Topline Data from the Phase 3 TRIDENT Trial Evaluating Earlier Use of Tumor Treating Fields Therapy in Newly Diagnosed Glioblastoma

June 18, 2026

From Novocure

Via Business Wire

CEO Sells 34K Shares of Biotech Stock, Valued at $615,000, According to Latest SEC Filing ↗

June 09, 2026

Via The Motley Fool

Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More ↗

May 30, 2026

Via The Motley Fool

3 Overlooked Stocks Set to Soar in 2026 ↗

May 05, 2026

Via The Motley Fool

NovoCure (NVCR) Q1 2026 Earnings Transcript ↗

April 30, 2026

Via The Motley Fool

Thursday's session: gap up and gap down stocks ↗

April 30, 2026

Via Chartmill

Novocure Reports First Quarter 2026 Financial Results

April 30, 2026

From Novocure

Via Business Wire

Novocure to Report First Quarter 2026 Financial Results

April 01, 2026

From Novocure

Via Business Wire

Novocure Announces Positive Topline Results from Phase 2 PANOVA-4 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Metastatic Pancreatic Cancer

March 26, 2026

From Novocure

Via Business Wire

Novocure Announces Optune Lua® Receives Reimbursement Approval in Japan for the Treatment of Non-Small Cell Lung Cancer

March 02, 2026

From Novocure

Via Business Wire

Novocure to Participate in 2026 Leerink Global Healthcare Conference

February 27, 2026

From Novocure

Via Business Wire

NovoCure (NVCR) Q4 2025 Earnings Call Transcript ↗

February 26, 2026

Via The Motley Fool

Frequently Asked Questions

Is NovoCure Limited - Ordinary Shares publicly traded?

Yes, NovoCure Limited - Ordinary Shares is publicly traded.

What exchange does NovoCure Limited - Ordinary Shares trade on?

NovoCure Limited - Ordinary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for NovoCure Limited - Ordinary Shares?

The ticker symbol for NovoCure Limited - Ordinary Shares is NVCR on the Nasdaq Stock Market

What is the current price of NovoCure Limited - Ordinary Shares?

The current price of NovoCure Limited - Ordinary Shares is 15.73

When was NovoCure Limited - Ordinary Shares last traded?

The last trade of NovoCure Limited - Ordinary Shares was at 07/15/26 01:08 PM ET

What is the market capitalization of NovoCure Limited - Ordinary Shares?

The market capitalization of NovoCure Limited - Ordinary Shares is 1.63B

How many shares of NovoCure Limited - Ordinary Shares are outstanding?

NovoCure Limited - Ordinary Shares has 2B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.